![Federica Pericle](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Federica Pericle
Gründer bei SeneXta Therapeutics SA
Aktive Positionen von Federica Pericle
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Onelife SA
![]() Onelife SA Investment ManagersFinance Onelife SA provides investment advice. The private company is based in Lugano, Switzerland. and has subsidiaries in Luxembourg, Switzerland and Liechtenstein. The Swiss company was founded in 2006 by Enrico Braglia. Enrico Braglia has been the CEO since 2006. | Berater | 01.05.2007 | - |
Analyst-Equity | 01.05.2007 | - | |
Portfolio Manager-Aktien | 01.05.2007 | - | |
SeneXta Therapeutics SA
![]() SeneXta Therapeutics SA Medical SpecialtiesHealth Technology SeneXta Therapeutics SA engages in the research and development of therapies for neurodegenerative disorders. The firm provides medicines that maintain healthy brain ageing and rehabilitation after ischemic brain injury. The company was founded by Enrico Braglia and Federica Pericle in 2008 and is headquartered in Lugano, Switzerland. | Geschäftsführer | 18.09.2009 | - |
Gründer | 18.09.2009 | - |
Karriereverlauf von Federica Pericle
Ehemalige bekannte Positionen von Federica Pericle
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Agilvax, Inc.
![]() Agilvax, Inc. BiotechnologyHealth Technology Agilvax, Inc. discovers and develops immunotherapies to combat cancer and targeted vaccines against infectious diseases. It optimizes lead immunotherapy candidates through an extensive in vitro and in vivo testing process to ensure clinical efficacy. The company was founded in 2011 and is headquartered in Albuquerque, NM. | Direktor/Vorstandsmitglied | 01.05.2013 | 25.07.2019 |
Vorstandsvorsitzender | 01.05.2013 | 25.07.2019 | |
Präsident | 01.05.2013 | 25.07.2019 | |
National Cancer Institute
![]() National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Federica Pericle
University of Turin | Doctorate Degree |
University of South Florida | Graduate Degree |
The University of Texas at Austin | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 5 |
Schweiz | 3 |
Italien | 2 |
Operativ
Analyst-Equity | 1 |
Consultant / Advisor | 1 |
Portfolio Manager-Equities | 1 |
Sektoral
Consumer Services | 4 |
Health Technology | 3 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
Onelife SA
![]() Onelife SA Investment ManagersFinance Onelife SA provides investment advice. The private company is based in Lugano, Switzerland. and has subsidiaries in Luxembourg, Switzerland and Liechtenstein. The Swiss company was founded in 2006 by Enrico Braglia. Enrico Braglia has been the CEO since 2006. | Finance |
SeneXta Therapeutics SA
![]() SeneXta Therapeutics SA Medical SpecialtiesHealth Technology SeneXta Therapeutics SA engages in the research and development of therapies for neurodegenerative disorders. The firm provides medicines that maintain healthy brain ageing and rehabilitation after ischemic brain injury. The company was founded by Enrico Braglia and Federica Pericle in 2008 and is headquartered in Lugano, Switzerland. | Health Technology |
National Cancer Institute
![]() National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
Agilvax, Inc.
![]() Agilvax, Inc. BiotechnologyHealth Technology Agilvax, Inc. discovers and develops immunotherapies to combat cancer and targeted vaccines against infectious diseases. It optimizes lead immunotherapy candidates through an extensive in vitro and in vivo testing process to ensure clinical efficacy. The company was founded in 2011 and is headquartered in Albuquerque, NM. | Health Technology |
- Börse
- Insiders
- Federica Pericle
- Erfahrung